patrys is a leader in igm antibody development, page-10

Andante I recognise the veracity of your comment and thank you for contributing. In spite of what Patrys has stated the shares are tightly held and Patrys has enticed on to it's board two of the most hard line and capable people in the industry., both of whom left high positions in large companies to join a minnow. Then we have the unbelievable fund raisiings where the public, , in one of these was excluded from participating an d in which all the "right" people were allocated shares at unbelievably low prices. Hence my continued questions as to what's really going on. Technology such as this at such an advanced stage cannot be selling at 2.4 cents when over 1 cent of this is cash. I repeat my question. What is going on? Give an opinion please, whatever it is.